115
Participants
Start Date
March 1, 2021
Primary Completion Date
June 1, 2023
Study Completion Date
June 1, 2023
ropivacaine
According to previous clinical experience, 0.5% ropivacaine was given in the subarachnoid cavity, and the initial dose was set at 2.5 mL (12.5mg). Dixon's up-and down method was adopted to adjust or down-adjust the dose of ropivacaine in the next patient according to the experimental results of the previous patient, and the adjusted dose was 0.1 mL (0.5mg).
Shengjing Hospital, Shengyang
Yanchao Yang
OTHER